Surgery Partners, Inc.
SGRY
$12.36
-$0.29-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.24% | 10.14% | 12.05% | 13.54% | 13.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.24% | 10.14% | 12.05% | 13.54% | 13.52% |
| Cost of Revenue | 7.39% | 9.74% | 12.45% | 13.88% | 13.02% |
| Gross Profit | 2.60% | 11.45% | 10.77% | 12.47% | 15.15% |
| SG&A Expenses | -14.78% | 5.58% | 4.65% | 15.89% | 14.72% |
| Depreciation & Amortization | 15.33% | 0.13% | 25.06% | 31.41% | 29.21% |
| Other Operating Expenses | 56.50% | 12.67% | 2.86% | -106.90% | -166.67% |
| Total Operating Expenses | 7.17% | 9.10% | 12.78% | 14.52% | 13.44% |
| Operating Income | 1.10% | 16.06% | 8.03% | 8.28% | 14.01% |
| Income Before Tax | -20.53% | 18.23% | -12.81% | -28.03% | 8.96% |
| Income Tax Expenses | -86.63% | 532.32% | 575.00% | 2,184.21% | 44,966.67% |
| Earnings from Continuing Operations | 691.20% | -77.98% | -96.59% | -107.64% | -90.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.10% | -17.01% | -13.44% | -14.89% | -22.69% |
| Net Income | 53.66% | -182.84% | -433.73% | -32,333.33% | -1,312.61% |
| EBIT | 1.10% | 16.06% | 8.03% | 8.28% | 14.01% |
| EBITDA | 4.56% | 12.06% | 11.83% | 13.20% | 17.38% |
| EPS Basic | 53.97% | -182.14% | -432.39% | -31,357.14% | -1,293.51% |
| Normalized Basic EPS | -1,798.70% | -4,358.06% | -463.96% | -316.33% | 94.94% |
| EPS Diluted | 53.73% | -182.04% | -428.20% | -76,790.00% | -1,261.02% |
| Normalized Diluted EPS | -1,798.70% | -4,358.06% | -463.96% | -312.00% | 83.33% |
| Average Basic Shares Outstanding | 0.86% | 0.58% | 0.46% | 0.38% | 0.41% |
| Average Diluted Shares Outstanding | 0.86% | 0.58% | 0.46% | 0.05% | 0.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |